25.54
-0.54 (-2.07%)
-0.54 (-2.07%)
Upgrade to Real-Time
Regular Market
Low
23.7899
High
67.74
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioXcel Therapeutics Inc | BTAI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.54 | -2.07% | 25.54 | 13:58:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 25.51 | 25.40 | 26.40 | 26.08 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 25.50 | 25.55 | 0.05 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,465 | 84,680 | $ 25.84 | $ 2,188,314 | - | 23.7899 - 67.74 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:58:59 | 3 | $ 25.53 | USD |
Period:
Draw Mode:
BioXcel Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 709.68M | 27.79M | 18.30M | $ - | $ - | -3.77 | -6.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -1.84M | 0.80% |
BioXcel Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTAI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 25.94 | 27.1702 | 23.7899 | 25.34 | 372,157 | -0.40 | -1.54% |
| 1 Month | 28.64 | 28.985 | 23.7899 | 26.63 | 386,757 | -3.10 | -10.82% |
| 3 Months | 31.03 | 38.9994 | 23.7899 | 30.68 | 404,255 | -5.49 | -17.69% |
| 6 Months | 48.73 | 67.74 | 23.7899 | 39.39 | 451,328 | -23.19 | -47.59% |
| 1 Year | 47.12 | 67.74 | 23.7899 | 43.37 | 495,806 | -21.58 | -45.8% |
| 3 Years | 9.58 | 74.89 | 2.41 | 36.61 | 317,701 | 15.96 | 166.6% |
| 5 Years | 11.02 | 74.89 | 2.41 | 35.86 | 289,465 | 14.52 | 131.76% |
BioXcel Therapeutics Description
| BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. |
